Harbin Pharmaceutical Group Co., Ltd. (600664) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Harbin Pharmaceutical Group Co., Ltd.

Why is Harbin Pharmaceutical Group Co., Ltd. ?

With a fall in EPS of -49.4%, the company declared Very Negative results in Sep 25

OPERATING CASH FLOW(Y) Lowest at CNY 281.12 MM
ROCE(HY) Lowest at 8.26%
INTEREST COVERAGE RATIO(Q) Lowest at 881.47

Below par performance in long term as well as near term

Along with generating -2.79% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Harbin Pharmaceutical Group Co., Ltd. for you?

Low Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Harbin Pharmaceutical Group Co., Ltd.

-9.56%

1.08

23.75%

China Shanghai Composite

13.33%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

7.78%

EBIT Growth (5y)

34.66%

EBIT to Interest (avg)

5.31

Debt to EBITDA (avg)

1.06

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

1.86

Tax Ratio

20.25%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

8.92%

ROE (avg)

9.35%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.62

EV to EBIT

11.62

EV to EBITDA

8.49

EV to Capital Employed

1.63

EV to Sales

0.56

PEG Ratio

Dividend Yield

ROCE (Latest)

14.02%

ROE (Latest)

10.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at 0.41 %

-22What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 281.12 MM

ROCE(HY)

Lowest at 8.26%

INTEREST COVERAGE RATIO(Q)

Lowest at 881.47

NET PROFIT(Q)

At CNY 68.89 MM has Fallen at -49.45%

RAW MATERIAL COST(Y)

Grown by 5.45% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 5.9 times

NET SALES(Q)

Lowest at CNY 3,896.55 MM

OPERATING PROFIT(Q)

Lowest at CNY 97.41 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 2.5 %

PRE-TAX PROFIT(Q)

At CNY 119.12 MM has Fallen at -37.91%

Here's what is working for Harbin Pharmaceutical Group Co., Ltd.

Debt-Equity Ratio

Lowest at 0.41 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Harbin Pharmaceutical Group Co., Ltd.

Operating Cash Flow

Lowest at CNY 281.12 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Interest Coverage Ratio

Lowest at 881.47

in the last five periods

MOJO Watch

The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Profit

At CNY 68.89 MM has Fallen at -49.45%

over average net sales of the previous four periods of CNY 136.29 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Net Sales

Lowest at CNY 3,896.55 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Operating Profit

Lowest at CNY 97.41 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 2.5 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

At CNY 119.12 MM has Fallen at -37.91%

over average net sales of the previous four periods of CNY 191.85 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 5.9 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 5.45% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income

Highest at CNY 0.28 MM

in the last five periods

MOJO Watch

Increased income from non business activities may not be sustainable

Non Operating income